Sage Therapeutics
SAGE
SAGE was delisted on the 30th of July, 2025.
92 hedge funds and large institutions have $1.08B invested in Sage Therapeutics in 2015 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 35 increasing their positions, 15 reducing their positions, and 12 closing their positions.
158% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 12
133% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 15
47% more capital invested
Capital invested by funds: $735M → $1.08B (+$345M)
26% more funds holding
Funds holding: 73 → 92 (+19)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$26.5M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17.2M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$16.7M |
| 4 |
ORI
Oak Ridge Investments
Chicago,
Illinois
|
+$16.6M |
| 5 |
DM
Deerfield Management
New York
|
+$14.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRV
Third Rock Ventures
Boston,
Massachusetts
|
-$82M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
-$16.3M |
| 3 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
-$5.29M |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$1.79M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.78M |
SAGE Hedge Fund Activity: Q1 2015 in Review
92 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q1 2015, worth a combined $1.08B — up 47% from $735M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new SAGE positions and 12 closed out — a net gain of 19 holders — while 35 added to existing stakes and 15 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $26.5M. The largest seller was Third Rock Ventures, cutting an estimated $82M.
- 92 institutional investors held Sage Therapeutics (SAGE) as of Q1 2015, up from 73 in Q4 2014.
- Funds reported $1.08B of Sage Therapeutics stock for Q1 2015, up 47% quarter-over-quarter.
- 31 funds opened new Sage Therapeutics positions in Q1 2015 and 12 closed out, a net change of +19 holders.
- The largest Sage Therapeutics buyer in Q1 2015 was JP Morgan Chase, an estimated $26.5M added.
- The largest Sage Therapeutics seller in Q1 2015 was Third Rock Ventures, an estimated $82M sold.
Based on aggregated 13F filings for Q1 2015.